Cargando…

NAC1 Modulates Sensitivity of Ovarian Cancer Cells to Cisplatin via Altering the HMGB1-Mediated Autophagic Response

Nucleus accumbens-1 (NAC1), a nuclear factor belonging to the BTB/POZ gene family, is known to play important roles in proliferation and growth of tumor cells and in chemotherapy resistance. Yet, the mechanisms underlying how NAC1 contributes to drug resistance remain largely unclear. We reported he...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, Cheng, Yan, Ren, Xingcong, Zhang, Li, Yap, Kai Lee, Wu, Hao, Patel, Rajesh, Liu, David, Qin, Zheng-Hong, Shih, Ie-Ming, Yang, Jin-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275651/ https://www.ncbi.nlm.nih.gov/pubmed/21743489 http://dx.doi.org/10.1038/onc.2011.290

Ejemplares similares

Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas
por: Ueda, Stefanie M., et al.
Publicado: (2010)

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway
por: Jinawath, Natini, et al.
Publicado: (2009)

Loss of NAC1 Expression Is Associated with Defective Bony Patterning in the Murine Vertebral Axis
por: Yap, Kai Lee, et al.
Publicado: (2013)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

NK cell HMGB1 mediates IL-2-induced “systemic autophagic” toxicity
por: Li, Guanqiao, et al.
Publicado: (2013)

Tumorous expression of NAC1 restrains antitumor immunity through the LDHA-mediated immune evasion
por: Ren, Yijie, et al.
Publicado: (2022)

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells
por: Gao, Min, et al.
Publicado: (2020)

NAC1 modulates autoimmunity by suppressing regulatory T cell–mediated tolerance
por: Yang, Jin-Ming, et al.
Publicado: (2022)

Inhibition of HMGB1 Suppresses Hepatocellular Carcinoma Progression via HIPK2-Mediated Autophagic Degradation of ZEB1
por: Zhu, Wei, et al.
Publicado: (2021)

Association of HMGB1, BRCA1 and P62 expression in ovarian cancer and chemotherapy sensitivity
por: Li, Shouyong, et al.
Publicado: (2018)

Expression of NAC1 Restrains the Memory Formation of CD8(+) T Cells during Viral Infection
por: Wang, Liqing, et al.
Publicado: (2022)

Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
por: Chavez-Dominguez, Rodolfo L., et al.
Publicado: (2021)

The Role of Forkhead Box Q1 Transcription Factor in Ovarian Epithelial Carcinomas
por: Gao, Min, et al.
Publicado: (2012)

Morin Hydrate Sensitizes Hepatoma Cells and Xenograft Tumor towards Cisplatin by Downregulating PARP-1-HMGB1 Mediated Autophagy
por: Pal Singh, Mahendra, et al.
Publicado: (2020)

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer
por: Fedoseienko, Alina, et al.
Publicado: (2016)

HMGB1 bound to cisplatin–DNA adducts undergoes extensive acetylation and phosphorylation in vivo
por: He, Yafeng, et al.
Publicado: (2015)

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
por: Zhou, Jinhua, et al.
Publicado: (2014)

DNA Damage Response is Prominent in Ovarian High-Grade Serous Carcinomas, Especially Those with Rsf-1 (HBXAP) Overexpression
por: Kshirsagar, Malti, et al.
Publicado: (2012)

Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis
por: He, Minjing, et al.
Publicado: (2023)

The Role of HMGB1 in Rheumatic Diseases
por: Dong, Yuanji, et al.
Publicado: (2022)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1
por: Tian, Songyu, et al.
Publicado: (2016)

Nuclear Fructose‐1,6‐Bisphosphate Inhibits Tumor Growth and Sensitizes Chemotherapy by Targeting HMGB1
por: Li, Yeyi, et al.
Publicado: (2023)

Cisplatin Protects against Acute Liver Failure by Inhibiting Nuclear HMGB1 Release
por: Li, Xun, et al.
Publicado: (2013)

The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer
por: Deng, Xinyue, et al.
Publicado: (2020)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

Amplification of The ch19p13.2 NACC1 Locus in Ovarian High-grade Serous Carcinoma
por: Shih, Ie-Ming, et al.
Publicado: (2011)

Retraction: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2020)

Increased Serum High Mobility Group Box 1 (HMGB1) Concentration and the Altered Expression of HMGB1 and Its Receptor Advanced Glycation Endproducts in Pemphigus
por: Li, Jia-Yi, et al.
Publicado: (2017)

HMGB1, a new proinflammatory molecule of interest in polymyositis and dermatomyositis patients
por: Grundtman, C, et al.
Publicado: (2003)

Novel dihydroartemisinin derivative DHA-37 induces autophagic cell death through upregulation of HMGB1 in A549 cells
por: Liu, Xiufeng, et al.
Publicado: (2018)

Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1
por: Zhou, Shilin, et al.
Publicado: (2023)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

Follicular fluid has more to offer: Insulin-like growth factor axis on ovarian carcinogenesis
por: Chu, Tiffany, et al.
Publicado: (2019)

MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1
por: Sun, Kai-Xuan, et al.
Publicado: (2015)

NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
por: Lin, Chao, et al.
Publicado: (2012)

HMGB1 in inflammation and cancer
por: Wang, Shumin, et al.
Publicado: (2020)

Morin Hydrate Reverses Cisplatin Resistance by Impairing PARP1/HMGB1-Dependent Autophagy in Hepatocellular Carcinoma
por: Singh, Mahendra Pal, et al.
Publicado: (2019)

HMGB1/2 can target DNA for illegitimate cleavage by the RAG1/2 complex
por: Zhang, Ming, et al.
Publicado: (2009)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fk4nrlcdli8376r49ahjce6t5c